Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and Mpro: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics
- PMID: 38907013
- DOI: 10.1007/s00249-024-01713-z
Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and Mpro: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics
Abstract
To find drugs against COVID-19, caused by the SARS-CoV-2, promising targets include the fusion of the viral spike with the human angiotensin-converting enzyme 2 (ACE2) as well as the main protease (Mpro). These proteins are responsible for viral entry and replication, respectively. We combined several state-of-the-art computational methods, including, protein-ligand interaction fingerprint, 3D-pharmacophores, molecular-docking, MM-GBSA, DFT, and MD simulations to explore two databases: ChEMBL and NANPDB to identify molecules that could both block spike/ACE2 fusion and inhibit Mpro. A total of 1,690,649 compounds from the two databases were screened using the pharmacophore model obtained from PLIF analysis. Five recent complexes of Mpro co-crystallized with different ligands were used to generate the pharmacophore model, allowing 4,829 compounds that passed this prefilter. These were then submitted to molecular docking against Mpro. The 5% top-ranked docking hits from docking result having scores -8.32 kcal mol-1 were selected and then docked against spike/ACE2. Only four compounds: ChEMBL244958, ChEMBL266531, ChEMBL3680003, and 1-methoxy-3-indolymethyl glucosinolate (4) displayed binding energies 8.21 kcal mol-1 (for the native ligand) were considered as putative dual-target inhibitors. Furthermore, predictive ADMET, MM-GBSA and DFT/6-311G(d,p) were performed on these compounds and compared with those of well-known antivirals. DFT calculations showed that ChEMBL244958 and compound 4 had significant predicted reactivity values. Molecular dynamics simulations of the docked complexes were run for 100 ns and used to validate the stability docked poses and to confirm that these hits are putative dual binders of the spike/ACE2 and the Mpro.
Keywords: 3D-pharmacophore; ACE2; Mpro; Quantum mechanics; SARS-CoV-2; Virtual screening.
© 2024. European Biophysical Societies' Association.
Similar articles
-
Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.Int J Biol Macromol. 2021 Nov 30;191:1114-1125. doi: 10.1016/j.ijbiomac.2021.09.146. Epub 2021 Sep 27. Int J Biol Macromol. 2021. PMID: 34592225 Free PMC article.
-
Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.J Mol Model. 2021 Jun 24;27(7):206. doi: 10.1007/s00894-021-04816-y. J Mol Model. 2021. PMID: 34169390 Free PMC article.
-
Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection.Sci Rep. 2024 May 27;14(1):12059. doi: 10.1038/s41598-024-60721-3. Sci Rep. 2024. PMID: 38802394 Free PMC article.
-
Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).Mini Rev Med Chem. 2021;21(6):689-703. doi: 10.2174/1389557520666201117111259. Mini Rev Med Chem. 2021. PMID: 33208074 Review.
-
Are protein-ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?Drug Discov Today. 2024 Oct;29(10):104137. doi: 10.1016/j.drudis.2024.104137. Epub 2024 Aug 14. Drug Discov Today. 2024. PMID: 39151594 Review.
References
-
- Becke AD (1988) Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A 38(6):3098–3100. https://doi.org/10.1103/physreva.38.3098 - DOI
-
- Bekono BD, Esmel AE, Dali B, Ntie-Kang F, Keita M, Owono LCO, Megnassan E (2021a) Computer-aided design of peptidomimetic inhibitors of falcipain-3: QSAR and pharmacophore models. Sci Pharm 89(4):44. https://doi.org/10.3390/scipharm89040044 - DOI
-
- Bekono BD, Sona AN, Eni DB, Owono LCO, Megnassan E, Ntie-Kang F (2021b) Molecular mechanics approaches for rational drug design: forcefields and solvation models. Physical Sciences Reviews 8(3):457–477. https://doi.org/10.1515/psr-2019-0128 - DOI
-
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28(1):235–242. https://doi.org/10.1093/nar/28.1.235 - DOI - PubMed - PMC
-
- Brooke GN, Filippo P (2020) Structural and functional modelling of SARS-CoV-2 entry in animal models. Sci Rep 10(1):15917. https://doi.org/10.1038/s41598-020-72528-z - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous